ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 126 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $564,000 | +2.9% | 386,100 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $548,000 | -18.9% | 386,100 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $676,000 | +2.4% | 386,100 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $660,000 | -10.1% | 386,100 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $734,000 | +23.8% | 386,100 | +23.8% | 0.00% | 0.0% |
Q4 2015 | $593,000 | -0.5% | 311,900 | 0.0% | 0.00% | -50.0% |
Q3 2015 | $596,000 | -52.6% | 311,900 | +15.2% | 0.00% | -33.3% |
Q2 2015 | $1,257,000 | +9.4% | 270,800 | +3.0% | 0.00% | 0.0% |
Q1 2015 | $1,149,000 | +35.3% | 263,000 | +7.4% | 0.00% | 0.0% |
Q4 2014 | $849,000 | -15.4% | 244,800 | +2.1% | 0.00% | -25.0% |
Q3 2014 | $1,004,000 | -29.7% | 239,700 | -1.7% | 0.00% | -20.0% |
Q2 2014 | $1,429,000 | -7.0% | 243,800 | 0.0% | 0.01% | -16.7% |
Q1 2014 | $1,536,000 | +39.6% | 243,800 | +29.6% | 0.01% | +50.0% |
Q4 2013 | $1,100,000 | +11.0% | 188,100 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $991,000 | -35.1% | 188,100 | -5.1% | 0.00% | -42.9% |
Q2 2013 | $1,526,000 | – | 198,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |